跳至主要内容
临床试验/JPRN-UMIN000002217
JPRN-UMIN000002217已完成1 期

Phase I/II study of intensity-modulated radiation therapy as trimodality therapy for malignant pleural mesothelioma. - Phase I/II study/IMRT/trimodality therapy for MPM

Department of Radiation Oncology and Image-Applied Therapy, Kyoto University Hospital0 个研究点目标入组 13 人开始时间: 2009年7月16日最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
13

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
ot applicable 至 75years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1.Patients with any previous thoracic surgery not intend to complete resection or chemotherapy except for CDDP/pemetrexed. 2.Patients with no adequate reconstoration of diaphragma. 3.Active another neoplasm or previous (wihin 5 years) malignansies 4.Previous radiotherapy to the chest 5.Serious heart disease, arrhythmia, hypofunction of residual lung, uncontrolled infection, pyschological difficulty 6.Uncontrolled diabetes, any complications need steroids therapies. 7.Not suitable for participating in the study for any reasons

研究者

发起方
Department of Radiation Oncology and Image-Applied Therapy, Kyoto University Hospital

相似试验